| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.19▼ | 7.19▼ | 7.13▲ | 7.10▼ | 7.23▼ |
| MA10 | 7.07▲ | 7.07▲ | 7.03▲ | 6.98▲ | 8.04▼ |
| MA20 | 6.98▲ | 7.01▲ | 7.01▲ | 7.15▼ | 8.74▼ |
| MA50 | 6.97▲ | 7.01▲ | 7.07▲ | 8.40▼ | 8.20▼ |
| MA100 | 7.12▲ | 7.23▼ | 7.41▼ | 8.80▼ | 13.28▼ |
| MA200 | 7.45▼ | 7.87▼ | 8.26▼ | 8.58▼ | 19.82▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.033▲ | 0.035▲ | 0.035▲ | 0.096▲ | -0.236▼ |
| RSI | 57.100▲ | 54.587▲ | 54.329▲ | 44.359▼ | 41.415▼ |
| STOCH | 87.939▲ | 88.250▲ | 75.706 | 56.108 | 10.486▼ |
| WILL %R | -39.506 | -28.070 | -28.070 | -47.712 | -89.275▼ |
| CCI | 58.952 | 61.092 | 73.064 | 18.448 | -95.000 |
|
Thursday, February 26, 2026 05:44 AM
Aligos Therapeutics, Inc. (NASDAQ: ALGS) is a clinical stage biopharmaceutical company founded with the mission to improve patient outcomes by developing best-in-class therapies for the treatment of ...
|
|
Monday, February 23, 2026 06:33 AM
The presentations can be found on the Posters & Presentations section of the Aligos website ( www.aligos.com) after the live event.
|
|
Wednesday, January 21, 2026 05:00 AM
SOUTH SAN FRANCISCO, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/02/26 | 7.36 | 7.383 | 6.95 | 7.03 | 21,963 |
| 26/02/26 | 6.99 | 7.50 | 6.905 | 7.50 | 25,397 |
| 25/02/26 | 7.06 | 7.10 | 6.73 | 6.94 | 34,079 |
| 24/02/26 | 7.00 | 7.25 | 6.85 | 7.09 | 20,085 |
| 23/02/26 | 6.85 | 7.1899 | 6.58 | 6.94 | 0 |
| 20/02/26 | 7.12 | 7.13 | 6.765 | 6.80 | 16,246 |
| 19/02/26 | 6.73 | 7.185 | 6.5941 | 7.12 | 24,528 |
| 18/02/26 | 6.59 | 7.07 | 6.59 | 6.80 | 21,653 |
| 17/02/26 | 6.97 | 6.97 | 6.23 | 6.68 | 66,187 |
| 13/02/26 | 7.01 | 7.71 | 6.905 | 6.91 | 50,031 |
|
|
||||
|
|
||||
|
|